The results of rank-sum tests showed that CEA levels in both the serum of COVID-19 patients (Additional file 6: Figure S2A) and the tissues of lung cancer (Additional file 6: Figure S2B-C) were significantly higher in smokers than in non-smokers. Here, CEACAM3 is linked to COVID-19.